Caption Management, LLC Nektar Therapeutics Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $112,263 - $552,544	175,411 New	175,411 $122,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $8,034 - $13,585	-2,643 Reduced 11.18%	21,000 $67,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $67,289 - $130,970	21,227 Added 878.6%	23,643 $90,000
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $255,414 - $434,181	-23,584 Reduced 90.71%	2,416 $33,000
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $1,764 - $2,543	135 Added 0.52%	26,000 $467,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $427,289 - $527,646	25,865 New	25,865 $444,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $157 - $190	-10 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $165 - $247	10 New	10 $0
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $325,220 - $479,429	-7,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $323,750 - $731,150	7,000 New	7,000 $342,000

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.